Frédéric Arsenault

Huot Daneault A, Desaulniers M, Beauregard JM, Beaulieu A, Arsenault F, April G, Turcotte É, Buteau FA

Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With 177Lu-DOTATATE: A Case Report

Front Endocrinol (Lausanne), 12 , 2021.

Résumé | Liens:

Del Prete M, Buteau FA, Arsenault F, Saighi N, Bouchard LO, Beaulieu A, Beauregard JM

Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial

Eur J Nucl Med Mol Imaging, 46 (3), 2019.

Résumé | Liens:

Del Prete M, Arsenault F, Saighi N, Zhao W, Buteau FA, Celler A, Beauregard JM

Accuracy and reproducibility of simplified QSPECT dosimetry for personalized Lu-octreotate PRRT

EJNMMI Phys, 5 (1), 2018.

Résumé | Liens:

Arsenault F, Beauregard JM, Pouliot F

Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy

Curr Opin Support Palliat Care, 12 (3), 2018.

Résumé | Liens: